Impax Laboratories Inc.

• Does Teva Have a Silver Lining?

  By Lior Cohen - April 22, 2013 | Tickers: IPXL, MRK, PFE, TEVA

  The weakness of Teva Pharmaceutical Industries (NYSE: TEVA) in the stock market is keeping away investors from this generic drug manufacturing giant. Next month the company will publish its financial reports for the first quarter of 2013. Will this company’s financial reports help rally its stock? Does the company have a silver lining that might pull shares of the company up in 2013?

  First, let’s examine the company more »

• J.P. Morgan Healthcare Conference Schedule: Day One

  By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ

  The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.

  I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)